Center for Disease Dynamics, Economics & Policy
Search this site:
Research Areas
Projects
Publications
Tools
News & Blog
Events
Researchers
About CDDEP
Weekly Digest: WHO approves semi-synthetic artemisinin, antibiotic preservation - a joint responsibility, and funding for AMFm
“Antibiotics Make You Fat”: A Chance for Readers to Weigh In
Weekly digest: Resistance in wildlife, malaria-proof mosquitoes, and the cost of infectious disease
Weekly digest: New CDDEP video on superbugs, resistant bacteria in turkey, and disease detecting rats
View all News & Blog posts »
Extending the Cure
Affordable Medicines Facility--Malaria
CDC Environmental Public Health Tracking Network Evaluation
Disease Control Priorities Network (DCPN)
Febrile Illness Diagnostics Project
Global Antibiotic Resistance Partnership
Golden Mustard
Malaria Atlas Project-- Elimination
Multiple First-line Therapies
Pneumococcal Modeling Project (PneuMOD)
The Lancet Commission on Investing in Health
View all projects »
Featured
Trends in Resistance to Carbapenems and Third-Generation Cephalosporins among Clinical Isolates of Klebsiella pneumoniae in the United States, 1999–2010
The Changing Epidemiology of Methicillin-Resistant Staphylococcus aureus in the United States: A National Observational Study
Hospital-Community Interactions Foster Coexistence between Methicillin-Resistant Strains of Staphylococcus aureus
Joint Statement on Antibiotic Resistance with the U.S. Centers for Disease Control and Prevention (CDC) and 25 National Health Organizations
View all publications »
Antibiotic Resistance
Disease Control Priorities
Environmental Health
Malaria
Alcohol and Tobacco
Health and Development
Where we work »
Graphics and presentations
Community-associated MRSA peaks in summer, as do skin and soft tissue infections
Life Cycle of the Malaria Parasite
Carbapenem and 3rd. gen. cephalosporin resistance among K. pneumoniae highest along the East Coast, but present in all regions of the country
Carbapenem and 3rd. gen. cephalosporin resistance among K. pneumoniae is increasing in all patient settings
View all tools »
What We Do
Board of Directors
Working at CDDEP
Annual Reports
Home
»
Tools
»
Update on Febrile Illness Rapid Diagnostic Tests Research & Development
View by Research Area
Antibiotic Resistance
Disease Control Priorities
Environmental Health
Malaria
Alcohol and Tobacco
Health and Development
View by Region
Africa
East Asia and Pacific
Europe and Central Asia
Latin America and Caribbean
Middle East and North Africa
North America
South Asia
View by Type
Code
Data
Graphic
Presentation
Where we work
Receive Updates
Email Address:
*
Update on Febrile Illness Rapid Diagnostic Tests Research & Development
Type:
Presentation
Publications:
The Future of the Affordable Medicines Facility-malaria: Will AMFm Play On?
Download this tool
